NewsRoom Articles - Page 632 of 1456

TuesdaySep 01, 2020 3:20 pm

Quantum Computing Inc. (OTCQB: QUBT) Starts Presentation at The LD 500

Quantum Computing Inc. (OTCQB: QUBT) is focused on developing novel applications and solutions utilizing quantum and quantum-ready computing techniques to solve difficult problems in various industries. The company leverages its team of experts in finance, computing, security, mathematics and physics to develop commercial applications for industries and government agencies that will need quantum computing power to solve their most challenging problems. For more information, visit the company's website at www.quantumcomputinginc.com About The LD 500 The LD 500 is the most ambitious project in LD Micro's 14-year history of leading the micro-cap space as an independent resource. Investors will enjoy updates…

TuesdaySep 01, 2020 3:20 pm

Biomerica Inc. (NASDAQ: BMRA) Starts Presentation at The LD 500

Biomerica Inc. (NASDAQ: BMRA) is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The company's products are designed to enhance the health and well-being of people, enable prevention and early detection of disease and reduce total health care costs. Biomerica primarily focuses on gastrointestinal and inflammatory diseases where the company has multiple diagnostic and therapeutic products in development. For more information, visit the company's website at www.biomerica.com About The…

TuesdaySep 01, 2020 3:20 pm

AutoWeb Inc. (NASDAQ: AUTO) Starts Presentation at The LD 500

AutoWeb Inc. (NASDAQ: AUTO) is a robust digital marketing platform providing high quality consumer leads, clicks and associated marketing services to automotive dealers and manufacturers throughout the United States. The company also provides consumers with robust and original online automotive content to help them make informed car-buying decisions. AutoWeb pioneered the automotive internet in 1995 and has since helped tens of millions of automotive consumers research vehicles; connected thousands of dealers nationwide with motivated car buyers; and helped every major automaker successfully market its brand online. For more information, visit the company's website at www.autoweb.com About The LD 500 The…

TuesdaySep 01, 2020 3:00 pm

IMV Inc. (NASDAQ: IMV) (TSX: IMV) Starts Presentation at The LD 500

IMV Inc. (NASDAQ: IMV) (TSX: IMV) is a clinical-stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of cancer-targeted immunotherapies and vaccines based on the company's proprietary drug delivery platform. This patented technology leverages a novel mechanism of action that enables the programming of immune cells in vivo, which are aimed at generating powerful new synthetic therapeutic capabilities. IMV's lead candidate, DPX-Survivac, is a T-cell-activating immunotherapy that combines the utility of the platform with a target: survivin. IMV is…

TuesdaySep 01, 2020 3:00 pm

Delcath Systems Inc. (NASDAQ: DCTH) Starts Presentation at The LD 500

Delcath Systems Inc. (NASDAQ: DCTH) is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company's investigational product, melphalan hydrochloride for injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS), is designed to administer high-dose chemotherapy to the liver while minimizing systemic exposure and associated side effects. In addition to the Phase 3 FOCUS trial, the company has initiated a global Phase 3 clinical trial for intrahepatic cholangiocarcinoma (ICC) called 'The ALIGN Trial'. Delcath is also evaluating other forms of metastatic liver cancers. For more information, visit the company's website at www.delcath.com About…

TuesdaySep 01, 2020 3:00 pm

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Starts Presentation at The LD 500

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence, machine-learning company that transforms data into knowledge. AnalytixInsight's financial analytics platform, CapitalCube.com, algorithmically analyzes market price data and regulatory filings to create insightful, actionable narratives and research on approximately 50,000 global companies and North American ETFs, providing high-quality financial research and content for investors, information providers, finance portals and media. AnalytixInsight also designs and implements workforce optimization solutions for large global enterprises. AnalytixInsight holds a 49% interest in MarketWall, a developer of fintech solutions for financial institutions. For more information, visit the company's website at AnalytixInsight.com About The LD 500…

TuesdaySep 01, 2020 3:00 pm

Acer Therapeutics Inc. (NASDAQ: ACER) Starts Presentation at The LD 500

Acer Therapeutics Inc. (NASDAQ: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of treatments for rare and life-threatening diseases with significant unmet medical needs. Acer's pipeline includes four clinical-stage candidates. Acer's product candidates present a relatively de-risked profile, having one or more of a favorable safety profile, clinical proof-of-concept data, mechanistic differentiation and/or accelerated paths for development through specific programs and procedures established by the FDA. For more information, visit the company's website at www.acertx.com About The LD 500 The LD 500 is the most ambitious project in LD Micro's 14-year history of leading the micro-cap…

TuesdaySep 01, 2020 2:40 pm

Data443 Risk Mitigation Inc. (OTC: ATDS) Starts Presentation at The LD 500

Data443 Risk Mitigation Inc. (OTC: ATDS) is an industry leader in all things data security, providing software and services to enable secure data across local devices, networks, clouds and databases, both at rest and in flight. Its suite of products and services is highlighted by: ARALOC, a market leading secure, cloud-based platform for the management, protection and distribution of digital content to desktop and mobile devices, which protects an organization's confidential content and intellectual property assets from leakage – malicious or accidental – without impacting collaboration between all stakeholders; ArcMail, a leading provider of simple, secure and cost-effective enterprise data…

TuesdaySep 01, 2020 2:40 pm

Milestone Scientific Inc. (NYSE American: MLSS) Starts Presentation at The LD 500

Milestone Scientific Inc. (NYSE American: MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient and virtually painless. Milestone's proprietary DPS Dynamic Pressure Sensing technology(R) is its technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional…

TuesdaySep 01, 2020 2:40 pm

Lantern Pharma Inc. (NASDAQ: LTRN) Starts Presentation at The LD 500

Lantern Pharma Inc. (NASDAQ: LTRN) is a clinical-stage biopharmaceutical company innovating the repurposing, revitalization and development of precision therapeutics in oncology. The company leverages advances in machine learning, genomics and artificial intelligence by using a proprietary A.I. platform to discover biomarker signatures that help identify patients more likely to respond to its pipeline of cancer therapeutics. Lantern's focus is to improve outcomes for patients by leveraging its technology to uncover, rescue and develop abandoned or failed drugs. Its current pipeline of three drugs, with two programs in clinical stages and two in preclinical, focuses on cancers that have unique and…